Published in Diabetes Care on July 13, 2007
Antioxidant strategies in the management of diabetic neuropathy. Biomed Res Int (2015) 0.83
Effect of ethnicity, dietary intake and physical activity on plasma adiponectin concentrations among malaysian patients with type 2 diabetes mellitus. Int J Endocrinol Metab (2013) 0.77
The effects of AGEing on diet. Am J Pathol (2008) 0.76
Benfotiamine counteracts smoking-induced vascular dysfunction in healthy smokers. Int J Vasc Med (2012) 0.75
Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr (2009) 2.71
Single oral challenge by advanced glycation end products acutely impairs endothelial function in diabetic and nondiabetic subjects. Diabetes Care (2007) 1.97
Pseudoxanthoma elasticum: genetics, clinical manifestations and therapeutic approaches. Surv Ophthalmol (2009) 1.92
Use of bacteriophage MS2 as an internal control in viral reverse transcription-PCR assays. J Clin Microbiol (2005) 1.89
Effects of n-3 fatty acids on macro- and microvascular function in subjects with type 2 diabetes mellitus. Am J Clin Nutr (2010) 1.75
Women and heart disease: the role of diabetes and hyperglycemia. Arch Intern Med (2004) 1.63
Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Clin Nutr (2007) 1.56
Effects of a rapeseed oil-enriched hypoenergetic diet with a high content of α-linolenic acid on body weight and cardiovascular risk profile in patients with the metabolic syndrome. Br J Nutr (2012) 1.47
Circulating calcitriol concentrations and total mortality. Clin Chem (2009) 1.38
SPP1 promoter polymorphisms: identification of the first modifier gene for pseudoxanthoma elasticum. Clin Chem (2007) 1.33
Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diabetes Care (2006) 1.31
Role of serum fetuin-A, a major inhibitor of systemic calcification, in pseudoxanthoma elasticum. Clin Chem (2005) 1.15
Pseudoxanthoma elasticum: genetic variations in antioxidant genes are risk factors for early disease onset. Clin Chem (2007) 1.14
Evaluation of novel broad-range real-time PCR assay for rapid detection of human pathogenic fungi in various clinical specimens. J Clin Microbiol (2008) 1.11
Poor outcome in end-stage heart failure patients with low circulating calcitriol levels. Eur J Heart Fail (2008) 1.06
Vascular endothelial growth factor gene polymorphisms as prognostic markers for ocular manifestations in pseudoxanthoma elasticum. Hum Mol Genet (2009) 1.05
Attenuation correction of myocardial SPECT perfusion images with low-dose CT: evaluation of the method by comparison with perfusion PET. J Nucl Med (2005) 1.04
Human xylosyltransferase II is involved in the biosynthesis of the uniform tetrasaccharide linkage region in chondroitin sulfate and heparan sulfate proteoglycans. J Biol Chem (2006) 1.03
High-volume extraction of nucleic acids by magnetic bead technology for ultrasensitive detection of bacteria in blood components. Clin Chem (2006) 1.03
23S rDNA real-time polymerase chain reaction of heart valves: a decisive tool in the diagnosis of infective endocarditis. Eur Heart J (2010) 1.00
Mutational analysis of the ABCC6 gene and the proximal ABCC6 gene promoter in German patients with pseudoxanthoma elasticum (PXE). Hum Mutat (2006) 0.99
A randomized controlled trial on the efficacy of carbohydrate-reduced or fat-reduced diets in patients attending a telemedically guided weight loss program. Cardiovasc Diabetol (2009) 0.98
Cloning and recombinant expression of active full-length xylosyltransferase I (XT-I) and characterization of subcellular localization of XT-I and XT-II. J Biol Chem (2006) 0.98
The local calcification inhibitor matrix Gla protein in pseudoxanthoma elasticum. Clin Biochem (2008) 0.98
Calcitriol deficiency and 1-year mortality in cardiac transplant recipients. Transplantation (2009) 0.97
Real-time polymerase chain reaction in transfusion medicine: applications for detection of bacterial contamination in blood products. Transfus Med Rev (2007) 0.97
Two novel real-time reverse transcriptase PCR assays for rapid detection of bacterial contamination in platelet concentrates. J Clin Microbiol (2004) 0.97
Interactions between endocarditis-derived Streptococcus gallolyticus subsp. gallolyticus isolates and human endothelial cells. BMC Microbiol (2010) 0.96
Good manufacturing practice-compliant expansion of marrow-derived stem and progenitor cells for cell therapy. Cell Transplant (2007) 0.96
Broad-range real-time PCR assay for the rapid identification of cell-line contaminants and clinically important mollicute species. Int J Med Microbiol (2008) 0.94
Cardiovascular complications in diabetes: targets and interventions. Diabetes Care (2008) 0.93
Enhanced reverse transcription-PCR assay for detection of norovirus genogroup I. J Clin Microbiol (2006) 0.93
Quantitative determination of the glycosaminoglycan Delta-disaccharide composition of serum, platelets and granulocytes by reversed-phase high-performance liquid chromatography. J Chromatogr A (2008) 0.93
Novel mutations in the ABCC6 gene of German patients with pseudoxanthoma elasticum. Hum Biol (2005) 0.92
Gene expression profiling of ABC transporters in dermal fibroblasts of pseudoxanthoma elasticum patients identifies new candidates involved in PXE pathogenesis. Lab Invest (2008) 0.92
Assessment of a rapid-cycle PCR assay for the identification of the recurrent c.3421C>T mutation in the ABCC6 gene in pseudoxanthoma elasticum patients. Lab Invest (2004) 0.92
Elevated xylosyltransferase I activities in pseudoxanthoma elasticum (PXE) patients as a marker of stimulated proteoglycan biosynthesis. J Mol Med (Berl) (2005) 0.91
Decorin GAG synthesis and TGF-β signaling mediate Ox-LDL-induced mineralization of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2011) 0.91
AGEs and methylglyoxal induce apoptosis and expression of Mac-1 on neutrophils resulting in platelet-neutrophil aggregation. Thromb Res (2007) 0.90
Pathobiology and cell interactions of platelets in diabetes. Diab Vasc Dis Res (2005) 0.90
Tropheryma whipplei Infection of an acellular porcine heart valve bioprosthesis in a patient who did not have intestinal Whipple's disease. J Clin Microbiol (2004) 0.90
Novel flow cytometry-based screening for bacterial contamination of donor platelet preparations compared with other rapid screening methods. Clin Chem (2009) 0.89
Differences in gene expression of human xylosyltransferases and determination of acceptor specificities for various proteoglycans. Biochem Biophys Res Commun (2009) 0.89
Analysis of the DXD motifs in human xylosyltransferase I required for enzyme activity. J Biol Chem (2004) 0.88
Human xylosyltransferase I: functional and biochemical characterization of cysteine residues required for enzymic activity. Biochem J (2005) 0.88
New ABCC6 gene mutations in German pseudoxanthoma elasticum patients. J Mol Med (Berl) (2004) 0.88
Coronary revascularization in diabetic patients: off-pump versus on-pump surgery. Ann Thorac Surg (2013) 0.88
Transforming growth factor beta1-regulated xylosyltransferase I activity in human cardiac fibroblasts and its impact for myocardial remodeling. J Biol Chem (2007) 0.86
Measurement of fibrosis marker xylosyltransferase I activity by HPLC electrospray ionization tandem mass spectrometry. Clin Chem (2006) 0.86
Skin autofluorescence increases postprandially in human subjects. Diabetes Technol Ther (2008) 0.86
Measurement of mycophenolic acid and its glucuronide using a novel rapid liquid chromatography-electrospray ionization tandem mass spectrometry assay. Clin Biochem (2008) 0.85
Impact of polymorphisms in the genes encoding xylosyltransferase I and a homologue in type 1 diabetic patients with and without nephropathy. Kidney Int (2005) 0.85
Scintigraphy for risk stratification of iodine-induced thyrotoxicosis in patients receiving contrast agent for coronary angiography: a prospective study of patients with low thyrotropin. J Clin Endocrinol Metab (2004) 0.84
Lipopolysaccharide-binding protein: a new biomarker for infectious endocarditis? Clin Chem (2008) 0.84
The formation of extracellular matrix during chondrogenic differentiation of mesenchymal stem cells correlates with increased levels of xylosyltransferase I. Stem Cells (2006) 0.84
Platelet activation markers in patients with heart assist device. Artif Organs (2005) 0.84
Elevated circulating levels of matrix metalloproteinases MMP-2 and MMP-9 in pseudoxanthoma elasticum patients. J Mol Med (Berl) (2009) 0.83
High-level expression and purification of human xylosyltransferase I in High Five insect cells as biochemically active form. Biochem Biophys Res Commun (2003) 0.83
The xylosyltransferase I gene polymorphism c.343G>T (p.A125S) is a risk factor for diabetic nephropathy in type 1 diabetes. Diabetes Care (2006) 0.83